科力遠(600478.SH):目前幹法電極的開發工作已順利完成小試,正在推進中試工作
格隆匯9月5日丨科力遠(600478.SH)在投資者互動平台表示,公司為響應下游重要客户的開發需求,主要針對固態電池核心零部件,開展幹法電極的技術開發。目前幹法電極的開發工作已順利完成小試,正在推進中試工作。現已實現自支撐膜的成捲成膜,三元正極自支撐膜壓實密度可達到3.6g/cm³,磷酸鐵鋰正極自支撐膜壓實密度可達到2.6g/ cm³,電池能量密度可提升10%以上。由於沒有使用有機溶劑,電極減少了與固態電解質發生副反應的風險,提高了電池的安全性和能量密度。同時,鑑於該技術的研發週期較長,公司將充分協調研發資源,加快開展技術的中試及後續工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.